Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 (Scientific Reports, (2022), 12, 1, (5207), 10.1038/s41598-022-09133-9)

Xiyuan Bai, Ashley M. Buckle, Eszter K. Vladar, Edward N. Janoff, Reeti Khare, Diane Ordway, David Beckham, Lorelenn B. Fornis, Abraham Majluf-Cruz, Randolph V. Fugit, Brian M. Freed, Soohyun Kim, Robert A. Sandhaus, Edward D. Chan

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this Article contained an error in the x-axis labels of Figure 5B, C, where in Figure 5B, the spacing of "−" and "+" indicators was incorrect and in Figure 5C, the "−" and "+" indicators were missing. The original Figure 5 and accompanying legend appear below. The original Article has been corrected.

Original languageEnglish (US)
Article number6466
JournalScientific reports
Volume12
Issue number1
DOIs
StatePublished - Dec 2022
Externally publishedYes

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19 (Scientific Reports, (2022), 12, 1, (5207), 10.1038/s41598-022-09133-9)'. Together they form a unique fingerprint.

Cite this